Literature DB >> 21515794

Posttranscriptional regulation of IL-23 expression by IFN-gamma through tristetraprolin.

Xuesong Qian1, Huan Ning, Jidong Zhang, Daniel F Hoft, Deborah J Stumpo, Perry J Blackshear, Jianguo Liu.   

Abstract

IL-23 plays an essential role in maintenance of IL-17-producing Th17 cells that are involved in the pathogenesis of several autoimmune diseases. Regulation of Th17 cells is tightly controlled by multiple factors such as IL-27 and IFN-γ. However, the detailed mechanisms responsible for IFN-γ-mediated Th17 cell inhibition are still largely unknown. In this study, we demonstrate that IFN-γ differentially regulates IL-12 and IL-23 production in both dendritic cells and macrophages. IFN-γ suppresses IL-23 expression by selectively targeting p19 mRNA stability through its 3'-untranslated region (3'UTR). Furthermore, IFN-γ enhances LPS-induced tristetraprolin (TTP) mRNA expression and protein production. Overexpression of TTP suppresses IL-23 p19 mRNA expression and p19 3'UTR-dependent luciferase activity. Additionally, deletion of TTP completely abolishes IFN-γ-mediated p19 mRNA degradation. We further demonstrate that IFN-γ suppresses LPS-induced p38 phosphorylation, and blockade of p38 MAPK signaling pathway with SB203580 inhibits IFN-γ- and LPS-induced p19 mRNA expression, whereas overexpression of p38 increases p19 mRNA expression via reducing TTP binding to the p19 3'UTR. Finally, inhibition of p38 phosphorylation by IFN-γ leads to TTP dephosphorylation that could result in stronger binding of the TTP to the adenosine/uridine-rich elements in the p19 3'UTR and p19 mRNA degradation. In summary, our results reveal a direct link among TTP, IFN-γ, and IL-23, indicating that IFN-γ-mediated Th17 cell suppression might act through TTP by increasing p19 mRNA degradation and therefore IL-23 inhibition.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21515794      PMCID: PMC3914637          DOI: 10.4049/jimmunol.1002672

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  46 in total

Review 1.  Tristetraprolin and other CCCH tandem zinc-finger proteins in the regulation of mRNA turnover.

Authors:  P J Blackshear
Journal:  Biochem Soc Trans       Date:  2002-11       Impact factor: 5.407

2.  Interleukin-17: an emerging role in lung inflammation.

Authors:  Jay K Kolls; Suzanne T Kanaly; Alistair J Ramsay
Journal:  Am J Respir Cell Mol Biol       Date:  2003-01       Impact factor: 6.914

3.  Evidence that tristetraprolin is a physiological regulator of granulocyte-macrophage colony-stimulating factor messenger RNA deadenylation and stability.

Authors:  E Carballo; W S Lai; P J Blackshear
Journal:  Blood       Date:  2000-03-15       Impact factor: 22.113

4.  Regulation of cyclooxygenase 2 mRNA stability by the mitogen-activated protein kinase p38 signaling cascade.

Authors:  M Lasa; K R Mahtani; A Finch; G Brewer; J Saklatvala; A R Clark
Journal:  Mol Cell Biol       Date:  2000-06       Impact factor: 4.272

5.  Activation of IL-27 p28 gene transcription by interferon regulatory factor 8 in cooperation with interferon regulatory factor 1.

Authors:  Jidong Zhang; Xuesong Qian; Huan Ning; Jianjun Yang; Huabao Xiong; Jianguo Liu
Journal:  J Biol Chem       Date:  2010-04-30       Impact factor: 5.157

6.  Interleukin-17 stimulates the expression of interleukin-8, growth-related oncogene-alpha, and granulocyte-colony-stimulating factor by human airway epithelial cells.

Authors:  Carol E Jones; Katie Chan
Journal:  Am J Respir Cell Mol Biol       Date:  2002-06       Impact factor: 6.914

Review 7.  IL-17: prototype member of an emerging cytokine family.

Authors:  Sudeepta Aggarwal; Austin L Gurney
Journal:  J Leukoc Biol       Date:  2002-01       Impact factor: 4.962

8.  Cutting edge: IFN-gamma is a negative regulator of IL-23 in murine macrophages and experimental colitis.

Authors:  Shehzad Z Sheikh; Katsuyoshi Matsuoka; Taku Kobayashi; Fengling Li; Tara Rubinas; Scott E Plevy
Journal:  J Immunol       Date:  2010-03-12       Impact factor: 5.422

9.  Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12.

Authors:  B Oppmann; R Lesley; B Blom; J C Timans; Y Xu; B Hunte; F Vega; N Yu; J Wang; K Singh; F Zonin; E Vaisberg; T Churakova; M Liu; D Gorman; J Wagner; S Zurawski; Y Liu; J S Abrams; K W Moore; D Rennick; R de Waal-Malefyt; C Hannum; J F Bazan; R A Kastelein
Journal:  Immunity       Date:  2000-11       Impact factor: 31.745

10.  Requirement of interleukin 17 receptor signaling for lung CXC chemokine and granulocyte colony-stimulating factor expression, neutrophil recruitment, and host defense.

Authors:  P Ye; F H Rodriguez; S Kanaly; K L Stocking; J Schurr; P Schwarzenberger; P Oliver; W Huang; P Zhang; J Zhang; J E Shellito; G J Bagby; S Nelson; K Charrier; J J Peschon; J K Kolls
Journal:  J Exp Med       Date:  2001-08-20       Impact factor: 14.307

View more
  29 in total

1.  Suppression of IL-12 production by tristetraprolin through blocking NF-kcyB nuclear translocation.

Authors:  Ling Gu; Huan Ning; Xuesong Qian; Qi Huang; Rong Hou; Rajaa Almourani; Mingui Fu; Perry J Blackshear; Jianguo Liu
Journal:  J Immunol       Date:  2013-08-30       Impact factor: 5.422

2.  Life without TTP: apparent absence of an important anti-inflammatory protein in birds.

Authors:  Wi S Lai; Deborah J Stumpo; Elizabeth A Kennington; Adam B Burkholder; James M Ward; David L Fargo; Perry J Blackshear
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2013-07-31       Impact factor: 3.619

Review 3.  Translating the Untranslated Region.

Authors:  Johannes Schwerk; Ram Savan
Journal:  J Immunol       Date:  2015-10-01       Impact factor: 5.422

4.  Fatal eosinophilic myocarditis develops in the absence of IFN-γ and IL-17A.

Authors:  Jobert G Barin; G Christian Baldeviano; Monica V Talor; Lei Wu; SuFey Ong; DeLisa Fairweather; Djahida Bedja; Natalie R Stickel; Jillian A Fontes; Ashley B Cardamone; Dongfeng Zheng; Kathleen L Gabrielson; Noel R Rose; Daniela Ciháková
Journal:  J Immunol       Date:  2013-09-18       Impact factor: 5.422

5.  A functional link between heme oxygenase-1 and tristetraprolin in the anti-inflammatory effects of nicotine.

Authors:  Md Jamal Uddin; Yeonsoo Joe; Min Zheng; Perry J Blackshear; Stefan W Ryter; Jeong Woo Park; Hun Taeg Chung
Journal:  Free Radic Biol Med       Date:  2013-10-02       Impact factor: 7.376

Review 6.  Tristetraprolin (TTP): interactions with mRNA and proteins, and current thoughts on mechanisms of action.

Authors:  Seth A Brooks; Perry J Blackshear
Journal:  Biochim Biophys Acta       Date:  2013-02-18

7.  Genetic polymorphisms in RNA binding proteins contribute to breast cancer survival.

Authors:  Rohit Upadhyay; Sandhya Sanduja; Vimala Kaza; Dan A Dixon
Journal:  Int J Cancer       Date:  2012-09-18       Impact factor: 7.396

8.  Mutant tristetraprolin: a potent inhibitor of malignant glioma cell growth.

Authors:  Esther A Suswam; John J Shacka; Kiera Walker; Liang Lu; Xuelin Li; Ying Si; Xiaowen Zhang; Lei Zheng; L Burt Nabors; Heping Cao; Peter H King
Journal:  J Neurooncol       Date:  2013-03-25       Impact factor: 4.130

9.  Tristetraprolin down-regulates IL-23 expression in colon cancer cells.

Authors:  Hyun Hee Lee; Song Soo Yang; Mai-Tram Vo; Wha Ja Cho; Byung Ju Lee; Sun-Hee Leem; Sang-Hyun Lee; Hee Jeong Cha; Jeong Woo Park
Journal:  Mol Cells       Date:  2013-11-29       Impact factor: 5.034

Review 10.  Exploring the RNA world in hematopoietic cells through the lens of RNA-binding proteins.

Authors:  Joan Yuan; Stefan A Muljo
Journal:  Immunol Rev       Date:  2013-05       Impact factor: 12.988

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.